etoposide has been researched along with tocophersolan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constantinou, AI; Constantinou, C; Hyatt, JA; Neophytou, CM; Papas, KA; Vraka, P | 1 |
| Bian, J; Cai, J; Luo, S; Tsend-Ayush, A; Wen, J; Yao, J; Yin, L; Yuan, Z; Zhou, J; Zhu, X | 1 |
| Beig, A; Dahan, A; Fine-Shamir, N; Lindley, D; Miller, JM; Porat, D | 1 |
| Beig, A; Dahan, A; Fine-Shamir, N | 1 |
4 other study(ies) available for etoposide and tocophersolan
| Article | Year |
|---|---|
Induction of DNA damage and caspase-independent programmed cell death by vitamin E.
Topics: Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Isomerism; Male; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Prostatic Neoplasms; Tocotrienols; Vitamin E | 2012 |
Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy.
Topics: Carcinoma, Hepatocellular; Drug Carriers; Etoposide; Glycyrrhetinic Acid; Humans; Micelles; Vitamin E | 2017 |
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide.
Topics: Administration, Oral; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Delivery Systems; Etoposide; Male; Permeability; Rats; Rats, Wistar; Solubility; Surface-Active Agents; Vitamin E | 2017 |
Adequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systems.
Topics: Administration, Oral; Animals; Biological Availability; Etoposide; Permeability; Polyethylene Glycols; Rats; Solubility; Vitamin E | 2021 |